众生药业(002317) - 2020 Q3 - 季度财报

Financial Performance - Operating revenue for the reporting period was ¥525,009,556.07, a decrease of 14.31% year-on-year, while total revenue from the beginning of the year to the reporting period was ¥1,310,310,490.10, down 31.72%[9] - Net profit attributable to shareholders was ¥109,818,793.43, an increase of 65.47% compared to the same period last year, but down 18.21% for the year-to-date figure of ¥301,480,673.30[9] - Basic earnings per share for the reporting period was ¥0.14, up 75.00% year-on-year, while year-to-date basic earnings per share decreased by 15.56% to ¥0.38[9] - The company achieved operating revenue of CNY 525.01 million and net profit attributable to shareholders of CNY 109.82 million for the reporting period[26] - Total operating revenue for the current period is CNY 525,009,556.07, a decrease from CNY 612,669,861.84 in the previous period[67] - Net profit for the current period is ¥298,925,208.11, a decrease of 19.5% compared to ¥371,186,003.48 in the previous period[87] - The total comprehensive income for the current period is CNY 111.62 million, compared to CNY 66.56 million in the previous period, representing an increase of about 67.7%[76] Cash Flow - The net cash flow from operating activities was ¥65,930,205.57, down 16.11% compared to the same period last year, but up 24.92% year-to-date[9] - The net cash flow from operating activities was approximately ¥360.59 million, an increase from ¥288.65 million, showing a growth of about 25%[100] - Cash inflow from investment activities was approximately ¥759.34 million, significantly up from ¥38.94 million, indicating a substantial increase[103] - The net cash flow from investment activities was approximately ¥253.77 million, recovering from a negative cash flow of ¥178.09 million in the previous period[103] - The ending balance of cash and cash equivalents was approximately ¥1.39 billion, up from ¥837.45 million, indicating a significant increase of about 65%[103] - The net increase in cash and cash equivalents was ¥545,971,100.92, contrasting with a decrease of ¥15,157,553.21 in the previous period[110] Assets and Liabilities - Total assets at the end of the reporting period reached ¥5,613,133,695.31, an increase of 1.94% compared to the previous year[9] - The company's cash and cash equivalents increased by 69.20% to CNY 1,387.23 million due to proceeds from the disposal of subsidiary equity and increased bank loans[26] - The total liabilities as of September 30, 2020, were CNY 1,317,156,277.68, a slight decrease from CNY 1,372,092,779.55, showing a reduction of about 4%[56] - The company's total equity increased to CNY 4,295,977,417.63 from CNY 4,134,483,611.32, marking an increase of approximately 3.9%[59] - Total current liabilities amounted to CNY 1,073,198,636.40, with short-term borrowings at CNY 549,257,974.04[117] - Total liabilities reached CNY 1,372,092,779.55, while total equity was CNY 4,134,483,611.32[120] Investments and Expenses - Non-operating income included a gain from the disposal of non-current assets amounting to ¥100,715,709.40, attributed to the disposal of subsidiary equity[9] - The company recognized investment income from the disposal of subsidiary equity, contributing to the increase in overall profits[26] - Research and development expenses increased to CNY 22,256,953.34 from CNY 21,575,627.56 year-over-year[70] - The company reported investment income of CNY 24,494,400.02, significantly higher than CNY 1,507,975.99 in the previous period[70] - The company reported a significant increase in credit impairment losses by 1,856.84% due to a decrease in accounts receivable[29] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 34,316[14] - The company did not identify any non-recurring gains or losses that were classified as recurring according to the relevant regulations[13] Changes in Financial Reporting - The company has implemented new revenue and leasing standards starting from 2020, which may affect future financial reporting[111] - The company has implemented new accounting policies effective from January 1, 2020, aligning with the new revenue recognition standards[129] - The third-quarter report has not been audited, which may affect the reliability of the financial data presented[130]